A detailed history of Gts Securities LLC transactions in Geron Corp stock. As of the latest transaction made, Gts Securities LLC holds 60,600 shares of GERN stock, worth $203,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,600
Previous 73,300 17.33%
Holding current value
$203,010
Previous $310,000 11.29%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.17 - $4.99 $105,042 - $125,698
-25,190 Reduced 29.02%
61,613 $279,000
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $145,523 - $238,939
46,943 Added 117.77%
86,803 $368,000
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $82,082 - $161,349
-46,904 Reduced 54.06%
39,860 $131,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $2,801 - $3,719
1,610 Added 1.89%
86,764 $183,000
Q3 2023

Nov 15, 2023

BUY
$2.11 - $3.28 $68,093 - $105,852
32,272 Added 61.03%
85,154 $180,000
Q2 2023

Aug 15, 2023

BUY
$1.97 - $3.69 $104,177 - $195,134
52,882 New
52,882 $170 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.